Amgen To Pay $25M To Escape Anemia Drug Kickback Suit
Amgen Inc., which pled guilty in December to misbranding its Aranesp anemia drug, will pay $24.9 million to settle a whistleblower suit alleging it paid kickbacks to pharmacy providers to promote...To view the full article, register now.
Already a subscriber? Click here to view full article